These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 15039315)

  • 1. Salivary secretory leukocyte protease inhibitor and oral candidiasis in human immunodeficiency virus type 1-infected persons.
    Chattopadhyay A; Gray LR; Patton LL; Caplan DJ; Slade GD; Tien HC; Shugars DC
    Infect Immun; 2004 Apr; 72(4):1956-63. PubMed ID: 15039315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary concentration of secretory leukocyte protease inhibitor, an antimicrobial protein, is decreased with advanced age.
    Shugars DC; Watkins CA; Cowen HJ
    Gerontology; 2001; 47(5):246-53. PubMed ID: 11490143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of oral secretory leukocyte protease inhibitor in HIV-infected subjects with long-term use of antiretroviral therapy.
    Nittayananta W; Kemapunmanus M; Yangngam S; Talungchit S; Sriplung H
    J Oral Pathol Med; 2013 Mar; 42(3):208-15. PubMed ID: 23126266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunity to Candida.
    Fidel PL
    Oral Dis; 2002; 8 Suppl 2():69-75. PubMed ID: 12164664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased serum and salivary immunoglobulins against Candida albicans in HIV-infected patients with oral candidiasis.
    Drobacheff C; Millon L; Monod M; Piarroux R; Robinet E; Laurent R; Meillet D
    Clin Chem Lab Med; 2001 Jun; 39(6):519-26. PubMed ID: 11506465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary secretory leukocyte protease inhibitor increases in HIV infection.
    Lin AL; Johnson DA; Stephan KT; Yeh CK
    J Oral Pathol Med; 2004 Aug; 33(7):410-6. PubMed ID: 15250833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal study of anti-Candida albicans mucosal immunity against aspartic proteinases in HIV-infected patients.
    Millon L; Drobacheff C; Piarroux R; Monod M; Reboux G; Laurent R; Meillet D
    J Acquir Immune Defic Syndr; 2001 Feb; 26(2):137-44. PubMed ID: 11242180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Th1/Th2 cytokine expression in saliva of HIV-positive and HIV-negative individuals: a pilot study in HIV-positive individuals with oropharyngeal candidiasis.
    Leigh JE; Steele C; Wormley FL; Luo W; Clark RA; Gallaher W; Fidel PL
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):373-80. PubMed ID: 9833746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anatomic dissociation between HIV-1 and its endogenous inhibitor in mucosal tissues.
    Wahl SM; Worley P; Jin W; McNeely TB; Eisenberg S; Fasching C; Orenstein JM; Janoff EN
    Am J Pathol; 1997 Apr; 150(4):1275-84. PubMed ID: 9094984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation and comparison of salivary secretory leukocyte protease inhibitor in human immunodeficiency virus patients and healthy individuals.
    Pushpanshu K; Sathawane RS; Kaushik R
    Indian J Palliat Care; 2014 Jan; 20(1):26-30. PubMed ID: 24600179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced secretory leukocyte protease inhibitor in human immunodeficiency virus type 1-infected patients.
    Baqui AA; Meiller TF; Falkler WA
    Clin Diagn Lab Immunol; 1999 Nov; 6(6):808-11. PubMed ID: 10548568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations among the use of highly active antiretroviral therapy, oral candidiasis, oral Candida species and salivary immunoglobulin A in HIV-infected children.
    Pomarico L; Cerqueira DF; de Araujo Soares RM; de Souza IP; de Araujo Castro GF; Socransky S; Haffajee A; Teles RP
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Aug; 108(2):203-10. PubMed ID: 19615660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonspecific secretory immunity in HIV-infected patients with oral candidiasis.
    Bard E; Laibe S; Clair S; Biichlé S; Millon L; Drobacheff C; Bettinger D; Seillès E; Meillet D
    J Acquir Immune Defic Syndr; 2002 Nov; 31(3):276-84. PubMed ID: 12439202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive study of Candida-specific antibodies in the saliva of human immunodeficiency virus-positive individuals with oropharyngeal candidiasis.
    Wozniak KL; Leigh JE; Hager S; Swoboda RK; Fidel PL
    J Infect Dis; 2002 May; 185(9):1269-76. PubMed ID: 12001044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salivary lactoferrin in HIV-infected children: correlation with Candida albicans carriage, oral manifestations, HIV infection and its antifungal activity.
    Alves TP; Simões AC; Soares RM; Moreno DS; Portela MB; Castro GF
    Arch Oral Biol; 2014 Aug; 59(8):775-82. PubMed ID: 24837476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candida-specific systemic cell-mediated immune reactivities in human immunodeficiency virus-positive persons with mucosal candidiasis.
    Leigh JE; Barousse M; Swoboda RK; Myers T; Hager S; Wolf NA; Cutright JL; Thompson J; Sobel JD; Fidel PL
    J Infect Dis; 2001 Jan; 183(2):277-285. PubMed ID: 11120933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral candidiasis is associated with low levels of parotid calprotectin in individuals with infection due to human immunodeficiency virus.
    Müller F; Frøland SS; Brandtzaeg P; Fagerhol MK
    Clin Infect Dis; 1993 Feb; 16(2):301-2. PubMed ID: 8443314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity.
    Jana NK; Gray LR; Shugars DC
    J Virol; 2005 May; 79(10):6432-40. PubMed ID: 15858026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary human beta-defensins affected by oral Candida status in Chinese HIV/AIDS patients undergoing ART.
    Liu Z; Yong X; Jiang L; Zhang L; Lin X; Liu W; Peng Y; Tao R
    Oral Dis; 2018 Sep; 24(6):964-971. PubMed ID: 29498794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic changes of Th1/Th2/Th17 cytokines and human beta defensin 2 in HIV-infected patients with oral candidiasis during the first year of highly active anti-retroviral therapy.
    Yong X; Liu Z; Jiang L; Tao R; Liu W; Zhang L; Peng Y; Lin X; Huang Y
    Arch Oral Biol; 2018 Aug; 92():62-67. PubMed ID: 29753928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.